Isradipine
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
64850-910 -
Package NDC
64850-910-01 -
Package NDC
64850-910-05 -
Application number
ANDA077169 -
SPL ID
194819ab-8bf2-4f80-b9bb-a1209af1ba21 -
SPL set ID
acf7c376-6cb6-4857-b455-0bf5da29346c -
UNII
YO1UK1S598 -
RxCUI
197848 -
RxCUI
197849
What the source publishes
- Labeler
- Elite Laboratories, Inc.
- Active ingredients
- Isradipine
- Form
- CAPSULE
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Isradipine",
"splId": "194819ab-8bf2-4f80-b9bb-a1209af1ba21",
"labels": [
{
"setId": "acf7c376-6cb6-4857-b455-0bf5da29346c",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=acf7c376-6cb6-4857-b455-0bf5da29346c",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=acf7c376-6cb6-4857-b455-0bf5da29346c"
}
],
"routes": [
"ORAL"
],
"labeler": "Elite Laboratories, Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "100 CAPSULE in 1 BOTTLE (64850-910-01)",
"package_ndc": "64850-910-01",
"identifierStatus": "well-formed",
"marketing_start_date": "20221228"
},
{
"sample": false,
"description": "500 CAPSULE in 1 BOTTLE (64850-910-05)",
"package_ndc": "64850-910-05",
"identifierStatus": "well-formed",
"marketing_start_date": "20221228"
}
],
"productId": "64850-910_194819ab-8bf2-4f80-b9bb-a1209af1ba21",
"useDomain": "unknown",
"dosageForm": "CAPSULE",
"productNdc": "64850-910",
"deaSchedule": null,
"genericName": "Isradipine",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "ISRADIPINE",
"strength": "2.5 mg/1"
}
],
"applicationNumber": "ANDA077169",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20221228",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000000069",
"N0000175421",
"M0006414"
],
"upc": [
"0364850911016",
"0364850910019"
],
"unii": [
"YO1UK1S598"
],
"rxcui": [
"197848",
"197849"
],
"spl_set_id": [
"acf7c376-6cb6-4857-b455-0bf5da29346c"
],
"pharm_class_cs": [
"Dihydropyridines [CS]"
],
"pharm_class_epc": [
"Dihydropyridine Calcium Channel Blocker [EPC]"
],
"pharm_class_moa": [
"Calcium Channel Antagonists [MoA]"
],
"manufacturer_name": [
"Elite Laboratories, Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:64850-910_194819ab-8bf2-4f80-b9bb-a1209af1ba21"